The Hospital of the University of Pennsylvania is establishing the Thrombosis and Hemostasis Pharmacy Residency Program, a comprehensive 52-week full-time commitment. The aim of this second-year pharmacy residency is to provide advanced training and clinical expertise to licensed pharmacists who have completed a PGY1 residency, in the specialized field of anticoagulation and hemostasis. The program focuses on developing skills and knowledge for various clinical roles, such as inpatient and outpatient anticoagulation management, consultation services, and active participation in anticoagulation stewardship programs.
Residents play a crucial role in the multidisciplinary team, ensuring the safe and effective use of anticoagulants, educating providers, patients, and caregivers, participating in selected meetings, and facilitating transitions between care settings. Longitudinal experiences encompass pharmacy operations, medication adherence assessments, clinical research, and professional development, including opportunities for presentations, teaching, mentoring, and writing.
The program is customized for each resident based on their goals, interests, and previous experience. Required rotations last one month, with elective rotations of varying lengths (two to four weeks) covering areas such as Benign Hematology Consult, Pulmonary Embolism Response Team (PeRT), Surgical Intensive Care Units, Ventricular Assisted Device clinic, and Pediatric Thrombosis program. Additionally, residents undergo a three-week clinical laboratory tutorial on hematologic interpretation, instrumentation in the hematology laboratory, and interpretation of coagulation studies.
Furthermore, the Outpatient Anticoagulation Management Center (AMC) functions as a multidisciplinary unit, overseeing the ambulatory anticoagulation requirements of more than 1400 patients annually. This collaborative team is comprised of nurse practitioners, pharmacists, clinicians, practicing nurses, and administrative staff who work collectively to deliver comprehensive anticoagulation care.
The anticoagulation pharmacy group actively engages in clinical research, collaborating on multiple projects with PGY1 and PGY2 residents each year. Residents also participate in ongoing prospective trials through enrollment and screening.
The Hospital of the University of Pennsylvania (HUP) is world-renowned for its clinical and research excellence, forging the way for newer and better ways to diagnose and treat illnesses and disorders. Its long and rich history of top-notch patient care began more than two centuries ago with the founding of the nation's first medical school, the University of Pennsylvania. Since 1765 when it first opened its doors, Penn has been dedicated to the training of medical professionals and the discovery and implementation of new medical knowledge. The world-class faculty and staff of the Hospital of the University of Pennsylvania are dedicated to superior patient care, education, and research for a better, healthier future. Their significant and groundbreaking contributions to medicine are recognized both nationally and internationally. The interdisciplinary team of professionals provides personalized care and service to patients — all within a compassionate and respectful environment. Innovative research coupled with responsive, hands-on care allows Penn to tailor treatment specifically to individual patient needs. HUP's reputation as a world leader in medical research and clinical care ...attracts the highest quality medical specialists from around the world. The supportive and collaborative environment encourages physicians and staff to keep reaching ahead to find new ways to improve the quality and length of life for everyone.